Al Ashi S, Shah R, Iftikhar N, Lingvay I, et al. Association of GLP1-receptor agonist use with liver disease progression, major cardiovascular events, and mortality in people with hepatic steatosis and diabetes. Diabetes Obes Metab 2025 Jul 30. doi: 10.1111/dom.16657.
PMID: 40735942